Strategies for advancing cancer nanomedicine

被引:670
|
作者
Chauhan, Vikash P. [1 ,2 ,3 ]
Jain, Rakesh K. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
关键词
HUMAN TUMOR XENOGRAFT; IN-VIVO; SOLID TUMORS; VASCULAR-PERMEABILITY; BREAST-CANCER; MICROVASCULAR PERMEABILITY; EXTRACELLULAR-MATRIX; LIPID-COMPOSITION; MOLECULAR-SIZE; DRUG-DELIVERY;
D O I
10.1038/nmat3792
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Cancer nanomedicines approved so far minimize toxicity, but their efficacy is often limited by physiological barriers posed by the tumour microenvironment. Here, we discuss how these barriers can be overcome through innovative nanomedicine design and through creative manipulation of the tumour microenvironment.
引用
收藏
页码:958 / 962
页数:5
相关论文
共 50 条
  • [41] Cancer nanomedicine
    Bhatia, Sangeeta N.
    Chen, Xiaoyuan
    Dobrovolskaia, Marina A.
    Lammers, Twan
    NATURE REVIEWS CANCER, 2022, 22 (10) : 550 - 556
  • [42] Cancer nanomedicine
    Sangeeta N. Bhatia
    Xiaoyuan Chen
    Marina A. Dobrovolskaia
    Twan Lammers
    Nature Reviews Cancer, 2022, 22 : 550 - 556
  • [43] Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms
    Kanwar, Jagat R.
    Samarasinghe, Rasika M.
    Kamalapuram, Sishir K.
    Kanwar, Rupinder K.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (18) : 1688 - 1695
  • [44] Advancing cancer care and prevention in the Caribbean: a survey of strategies for the region
    Spence, Dingle
    Argentieri, M. Austin
    Andall-Brereton, Glennis
    Anderson, Benjamin O.
    Duggan, Catherine
    Bodkyn, Curt
    Bray, Freddie
    Gibson, Tracey
    Garcia, Wendy Gomez
    Greaves, Natalie
    Gupta, Sumit
    Hobday, Virginia
    McLean, Felicia
    Mery, Les
    Nimrod, Marisa
    Ocho, Oscar
    Quee-Brown, Corrine Sin
    Tortolero-Luna, Guillermo
    Shields, Alexandra E.
    LANCET ONCOLOGY, 2019, 20 (09): : E522 - E534
  • [45] Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives
    Buocikova, Verona
    Rios-Mondragon, Ivan
    Pilalis, Eleftherios
    Chatziioannou, Aristotelis
    Miklikova, Svetlana
    Mego, Michal
    Pajuste, Karlis
    Rucins, Martins
    El Yamani, Naouale
    Longhin, Eleonora Marta
    Sobolev, Arkadij
    Freixanet, Muriel
    Puntes, Victor
    Plotniece, Aiva
    Dusinska, Maria
    Cimpan, Mihaela Roxana
    Gabelova, Alena
    Smolkova, Bozena
    CANCERS, 2020, 12 (12) : 1 - 32
  • [46] Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies
    Walweel, Nada
    Aydin, Omer
    ACS OMEGA, 2024, 9 (26): : 27832 - 27852
  • [47] Nanomedicine strategies for targeting skin inflammation
    Abdel-Mottaleb, Mona M. A.
    Try, Celine
    Pellequer, Yann
    Lamprecht, Alf
    NANOMEDICINE, 2014, 9 (11) : 1727 - 1743
  • [48] Tumor vasculature associated nanomedicine strategies
    Wang, Xiaorui
    Song, Xuejiao
    Wei, Qinglin
    Wang, Wenjun
    Xu, Huae
    Dong, Xiaochen
    COORDINATION CHEMISTRY REVIEWS, 2024, 521
  • [49] Nanomedicine Advancing from Bench to Bedside: the Role of Polymeric Materials
    Ciardelli, Gianluca
    Decuzzi, Paolo
    POLYMER INTERNATIONAL, 2016, 65 (07) : 733 - 733
  • [50] RNA Nanomedicine: Delivery Strategies and Applications
    Junho Byun
    Yina Wu
    Jinwon Park
    Jung Suk Kim
    Qiaoyun Li
    Jaehyun Choi
    Namjo Shin
    Meng Lan
    Yu Cai
    Jaiwoo Lee
    Yu-Kyoung Oh
    The AAPS Journal, 25